Insider & Political Trading

Official filings, normalized for faster research

Previous-day view · Mon Sep 14 close. You are previewing the previous trading day. Subscribe to see today live and every other date — plans start at Delta, $39/mo. Sign up Sign in

Desk brief

AI Sep 14

The tape was heavily sell-skewed: 473 filings reported about $154.2M bought versus $745.9M sold, with only one congressional disclosure.

Two insider buying clusters — Cluster buying led the notable signals: four insiders bought roughly $671.5K of PMTS across four filers, while four bought about $992.1K of GPUS across four filers. PMTS GPUS

Multiple insider selling clusters — Selling clusters were broader and larger, including five insiders selling about $18.6M of CHYM, four selling $17.4M of DBX, seven selling $9.2M of COST, three selling $2.1M of IOT, and 11 selling $2.2M of LOGI. CHYM DBX COST IOT LOGI

Cascade added heavily to RSG — Cascade Investment, L.l.c. bought roughly $453.0M of RSG and was also flagged as a 10% owner adding about $453.4M. RSG was the most bought ticker over 14 days at about $695.1M from one filer. RSG L.l.c. Cascade Investment

Largest reported purchase — Over the past 14 days, Bluearc Capital Management, Llc reported the largest purchase at roughly $99.4M of PBLSX. The broader period remained sell-heavy, with about $1.4B bought versus $13.0B sold. PBLSX Llc Bluearc Capital Management

The filings to keep on the tape were the four-filer buying clusters in PMTS and GPUS versus the larger insider selling clusters in CHYM, DBX, COST, IOT, and LOGI. YPF remained the most sold ticker over 14 days at about $5.3B across 22 filers, followed by APGE at about $1.1B across nine filers.

AI-generated from the filings on this page — not financial advice.

Filings · Sep 14

1039

Latest about 14 hours ago

Disclosed buying · 14d

$1.37B

1080 purchases across 1465 tickers

Disclosed selling · 14d

$12.97B

6075 sales and dispositions

Tape lean · 14d

Heavy selling

Largest buy: PBLSX $99.38M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings

Most bought

Most sold

Signals

Fixed rules over the last 21 days — see each card for why it fired

Cluster selling CHYM

7 insiders sold $209.03M about 14 hours ago

Cluster selling PMTS

9 insiders sold $55.22M about 15 hours ago

Cluster selling DK

9 insiders sold $3.34M about 15 hours ago

Cluster selling ROIV

7 insiders sold $9.26M about 15 hours ago

Cluster selling PCOR

5 insiders sold $8.15M about 16 hours ago

Cluster selling THC

4 insiders sold $37.02M about 16 hours ago

Cluster buying PMTS

5 insiders bought $11.96M about 16 hours ago

$1M+ insider buy PMTS

Tricor Pmt25 Holdings Inc. bought $11.29M about 16 hours ago

10% owner adding PMTS

Tricor Pmt25 Holdings Inc. added $11.29M about 16 hours ago

Executive buy DVN

Gaspar Clay M bought $199.88K about 17 hours ago

Cluster buying GPUS

4 insiders bought $1.14M about 17 hours ago

Cluster selling FIGR

3 insiders sold $20.39M about 17 hours ago

Disclosure sentiment

Who is buying against who is selling · 90 days · −100 to +100

Accumulation

AMR 26 buys · 0 sells +100

AAT 17 buys · 0 sells +100

RCG 52 buys · 0 sells +100

SUJA 22 buys · 0 sells +100

DLHC 43 buys · 0 sells +100

UUU 32 buys · 0 sells +100

Distribution

UTHR 0 buys · 496 sells -100

CRWV 0 buys · 785 sells -100

DELL 0 buys · 651 sells -100

SE 0 buys · 468 sells -100

NET 0 buys · 277 sells -100

STX 0 buys · 240 sells -100

Bullish and bearish sectors

Net disclosed value · 30 days

Buying extends right, selling left. A company in more than one industry counts in each.

631 filings

Official insider and political disclosure transactions
Filed	Transaction	Issuer / asset	Reporting person	Qty / price	Value	Source
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Stock Options (Right to Buy) on Common Stock	Elze Christian Insider Director	17,000 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Restricted Stock Units on Common Stock	Melincoff Gwen A Insider Director	8,500 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Stock Options (Right to Buy) on Common Stock	Boudes Pol F Insider Director	17,000 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 3, 2026 Restricted Stock Units on Common Stock			8,500 shares @ $0 Direct ownership	$0
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Restricted Stock Units on Common Stock	Bashan Dror Insider President And CEO	160,000 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Restricted Stock Units on Common Stock	Bar-shalev Amos Insider Director	8,500 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 3, 2026 Stock Options (Right to Buy) on Common Stock			17,000 shares @ $0 Direct ownership	$0
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Stock Option (Right to Buy) on Common Stock	Bashan Dror Insider President And CEO	320,000 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Restricted Stock Units on Common Stock	Ben Zvi Shmuel Insider Director	8,500 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 3, 2026 Stock Options (Right to Buy) on Common Stock			17,000 shares @ $0 Direct ownership	$0
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Restricted Stock Units on Common Stock	Forster Eliot Insider Director	8,500 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 3, 2026 Stock Options (Right to Buy) on Common Stock			17,000 shares @ $0 Direct ownership	$0
Sep 3, 2026 2-day lag	Exercise Sep 1, 2026	IOVA Iovance Biotherapeutics, Inc. Common Stock	Vogt Frederick G Insider Interim CEO & General Counsel	41,669 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Exercise Sep 1, 2026 Restricted Stock Units on Common stock			41,669 shares @ $0 Direct ownership	$0
Same filing as the row above	Disposition Sep 1, 2026 Common Stock			17,702 shares @ $8.28 Direct ownership	$146.57K
Sep 3, 2026 2-day lag	Exercise Sep 1, 2026	IOVA Iovance Biotherapeutics, Inc. Common Stock	Puri Raj K. Insider Chief Regulatory Officer	5,470 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Exercise Sep 1, 2026 Restricted Stock Units on Common stock			5,470 shares @ $0 Direct ownership	$0
Same filing as the row above	Disposition Sep 1, 2026 Common Stock			2,508 shares @ $8.28 Direct ownership	$20.77K
Sep 3, 2026 2-day lag	Exercise Sep 1, 2026	IOVA Iovance Biotherapeutics, Inc. Restricted Stock Units on Common stock	Bilinsky Igor Insider Chief Operating Officer	8,789 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Exercise Sep 1, 2026 Common Stock			8,789 shares @ $0 Direct ownership	$0
Same filing as the row above	Disposition Sep 1, 2026			4,472 shares @ $8.28 Direct ownership	$37.03K
Sep 3, 2026 2-day lag	Award Sep 1, 2026	SYY Sysco Corp Common Stock	Sewell Brandon Elliot Insider Interim CFO	3,285 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 2, 2026 2-day lag	Gift Aug 31, 2026	ADPT Adaptive Biotechnologies Corp Common Stock	Owen Katey Einterz Insider Director	12,539 shares Direct ownership	Not reported	SEC Form 4
Sep 1, 2026 Same-day filing	Award Sep 1, 2026	EDSA Edesa Biotech, Inc. Common Shares	Nijhawan Pardeep Insider Chief Executive Officer	5,714 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 1, 2026 4-day lag	Buy Aug 28, 2026	MAIA Maia Biotechnology, Inc. Common Stock	Guerrero Ramiro Insider Director	46,620 shares @ $1.35 Direct ownership	$62.94K	SEC Form 4